July 12, 2010 | AlphaRx Announces the Podium Presentation of GAI-122 Injectable Nanoemulsion for Neuroprotection at Controlled Release Society Annual Meeting |
|
June 29, 2010 | AlphaRx Regains Rights to Indaflex™ |
|
May 10, 2010 | AlphaRx Provides Update on Indaflex |
|
April 29, 2010 | AlphaRx Provides Corporate Update |
|
March 29, 2010 | AlphaRx Plans to List Subsidiary |
|
January 21, 2010 | AlphaRx and Gaia BioPharma Secure Phase I/II Manufacturer For GAI-122 and unveil Their Clinical Development Strategy |
|
December 21, 2009 | AlphaRx's Newly Appointed President of China Operations Unveils Strategic Corporate Initiatives |
|
December 17, 2009 | AlphaRx Signs Contract Manufacturing Agreement for ARX1088 |
|
December 14, 2009 | AlphaRx Appoints President for its China Operations |
|
December 3, 2009 | AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai |
|
September 30, 2009 | AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement |
|
September 14, 2009 | AlphaRx Presents Company Overview and New Product Candidates at the Rodman & Renshaw Healthcare Conference |
|
September 3, 2009 | ALPHARx to Present at Rodman Renshaw Annual Global Investment Conference |
|
August 27, 2009 | AlphaRx Concludes GAI-122 Formulation Development Intended For The Prevention of Delirium |
|
August 17, 2009 | AlphaRx Completes Lyophilization Process for Zysolin™ |
|
August 10, 2009 | AlphaRx Receives China Patent on Its Drug Delivery Platform |
|
August 4, 2009 | AlphaRx and Venturepharm Announce Collaboration Agreement |
|
July 23, 2009 | AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting |
|
July 21, 2009 | AlphaRx Unveils its China Strategy |
|
July 9, 2009 | AlphaRx Reports Positive Preclinical Data on GAI-122 Against Liver Disease |
|
Jnue 29, 2009 | AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium |
|
June 24, 2009 | AlphaRx Shareholder Update |
|
June 18, 2009 | Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans |
|
June 16, 2009 | AlphaRx and Gaia BioPharma Provide GAI-122 Development Update |
|
October 22, 2008 | AlphaRx and Gaia BioPharma Enter Into Feasibility and Option Agreement |
|
August 12, 2008 | AlphaRx Receives Conditional Approval to List on the TSX |
|
June 26, 2008 | Zysolin™ Improves Survival in Pivotal Animal Studies |
|
June 3, 2008 | Zysolin Shows Promising Results in Animal Study |
|
May 27, 2008 | AlphaRx Signs Cooperative Research and Development Agreement with US Army |
|
May 20, 2008 | AlphaRx Provides Corporate and Development Update |
|
March 25, 2008 | AlphaRx Announces Non-Brokered Private Placement |
|
January 29 2008 | AlphaRx Initiates Indaflex™ China Registration |
|
January 9, 2008 | AlphaRx CEO Accumulates More Company Shares
|
Investors | Press Releases